Вы находитесь на странице: 1из 186

Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph.

D
Department of Pharmaceutics KLE Universitys College of Pharmacy BELGAUm 590010, Karnataka, India Cell No: 00919742431000 E-mail: bknanjwade@yahoo.co.in
08/10/2010 KLECOP, Nipani 1

CONTENTS

Introduction of absorption. Structure of the Cell Membrane. Gastro intestinal absorption of drugs. Mechanism of Drug absorption. Factors affecting drug absorption Absorption of drugs from non-per oral routes Methods of determining absorption References.
KLECOP, Nipani 2

08/10/2010

Introduction of Absorption

Definition : The process of movement of unchanged drug from the site of administration to systemic circulation.

There always exist a correlation between the plasma concentration of a drug & the therapeutic response & thus, absorption can also be defined as the process of movement of unchanged drug from the site of administration to the site of measurement. i.e., plasma.
KLECOP, Nipani 3

08/10/2010

Therapeutic success of a rapidly & completely absorbed drug. Plasma Drug Minimum effective conc. Therapeutic failure of a slowly absorbed drug. Subtherapeutic level

Conc.

Not only the magnitude of drug that comes into the systemic circulation but also the rate at which it is absorbed is important this is clear from the figure.

Time

08/10/2010

KLECOP, Nipani

08/10/2010

KLECOP, Nipani

CELL MEMBRANE

Also called the plasma membrane, plasmalemma or phospholipid bilayer. The plasma membrane is a flexible yet sturdy barrier that surrounds & contains the cytoplasm of a cell. Cell membrane mainly consists of: 1. Lipid bilayer-phospholipid -Cholesterol -Glycolipids. 2. Proitens-Integral membrane proteins -Lipid anchored proteins -Peripheral Proteins
KLECOP, Nipani 6

08/10/2010

LIPID BILAYER

08/10/2010

KLECOP, Nipani

LIPID BILAYER

The basic structural framework of the plasma membrane is the lipid bilayer. Consists primarily of a thin layer of amphipathic phospholipids which spontaneously arrange so that the hydrophobic tail regions are shielded from the surrounding polar fluid, causing the more hydrophilic head regions to associate with the cytosolic & extracellular faces of the resulting bilayer. This forms a continuous, spherical lipid bilayer app. 7nm thick.
KLECOP, Nipani 8

08/10/2010

It consists of two back to back layers made up of three types: Phospholipid, Cholesterol, Glycolipids. 1) Phospholipids :
Principal type of lipid in membrane about 75 %. Contains polar and non polar region. Polar region is hydrophilic and non polar region is hydrophobic. Non polar head contain two fatty acid chain. One chain is straight fatty acid chain.( Saturated ) Another tail have cis double bond and have kink in tail. ( Unsaturated )
08/10/2010 KLECOP, Nipani 9

CHOLESTEROL

Amount in membrane is 20 %. Insert in membrane with same orientation as phospholipids molecules. Polar head of cholesterol is aligned with polar head of phospholipids.

FUNCTION: Immobilize first few hydrocarbons groups phospholipids molecules. Prevents crystallization of hydrocarbons & phase shift in membrane
08/10/2010 KLECOP, Nipani 10

OH

08/10/2010

KLECOP, Nipani

11

08/10/2010

KLECOP, Nipani

12

GLYCOLIPIDS

Another component of membrane lipids present about 5 %. Carbohydrate groups form polar head. Fatty acids tails are non polar. Present in membrane layer that faces the extracellular fluid. This is one reason due to which bilayer is asymmetric. FUNCTIONS: Protective Insulator Site of receptor binding
KLECOP, Nipani 13

08/10/2010

08/10/2010

KLECOP, Nipani

14

COMPOSITION OF PROTEINS
PROTEINS

INTEGRAL PROTEINS

LIPID ANCHORED PROTEINS


KLECOP, Nipani

PERIPHERAL PROTEINS

08/10/2010

15

INTEGRAL PROTEINS

Also known as Transmembrane protein. Have hydrophilic and hydrophobic domain. Hydrophobic domain anchore within the cell membrane and hydrophilic domain interacts with external molecules. Hydrophobic domain consists of one, multiple or combination of helices and sheets protein mofits. Ex. Ion Channels, Proton pump, GPCR.
KLECOP, Nipani 16

08/10/2010

LIPID ANCHORED PROTEIN

Covalently bound to single or multiple lipid molecules. Hydrophobically inert into cell membrane & anchor the protein. The protein itself is not in contact with membrane. Ex. G Proteins.
KLECOP, Nipani 17

08/10/2010

PERIPHERAL PROTEINS

Attached to integral membrane proteins OR associated with peripheral regions of lipid bilayer. Have only temporary interaction with biological membrane. Once reacted with molecule, dissociates to carry on its work in cytoplasm. Ex. Some Enzyme, Some Hormone
KLECOP, Nipani 18

08/10/2010

GASTRO INTESTINAL ABSORPTION OF DRUGS

08/10/2010

KLECOP, Nipani

19

Stomach :
The surface area for absorption of drugs is relatively small in the stomach due to the absence of macrovilli & microvilli. Extent of drug absorption is affected by variation in the time it takes the stomach to empty, i.e., how long the dosage form is able to reside in stomach. Drugs which are acid labile must not be in contact with the acidic environment of the stomach. Stomach emptying applies more to the solid dosage forms because the drug has to dissolve in the GI fluid before it is available for absorption. Since solubility & dissolution rate of most drugs is a function of pH, it follows that, a delivery system carrying a drug that is predominantly absorbed from the stomach, must stay in the stomach for an extended period of time in order to assure maximum dissolution & therefore to extent of absorption.

08/10/2010

KLECOP, Nipani

20

Small Intestine :
The drugs which are predominantly absorbed through the small intestine, the transit time of a dosage form is the major determinant of extent of absorption. Various studies to determine transit time: Early studies using indirect methods placed the average normal transit time through the small intestine at about 7 hours. These studies were based on the detection of hydrogen after an oral dose of lactulose. (Fermentation of lactulose by colon bacteria yields hydrogen in the breath).

08/10/2010

KLECOP, Nipani

21

Small Intestine : Newer studies suggest the transit time to be about 3 to


4 hours. Use gamma scintigraphy. Thus, if the transit time in small intestine for most healthy adults is between 3 to 4 hours, a drug may take about 4 to 8 hours to pass through the stomach & small intestine during fasting state. During the fed state, the small intestine transit time may take about 8 to 12 hours.
KLECOP, Nipani 22

08/10/2010

Large intestine :
The major function of large intestine is to absorb water from ingestible food residues which are delivered to the large intestine in a fluid state, & eliminate them from the body as semi solid feces.
Only a few drugs are absorbed in this region.

08/10/2010

KLECOP, Nipani

23

MECHANISM OF DRUG ABSORPTION


1) Passive diffusion 2) Pore transport 3) Carrier- mediated transport a) Facilitated diffusion b) Active transport 4) Ionic or Electrochemical diffusion 5) Ion-pair transport 6) Endocytosis
08/10/2010 KLECOP, Nipani 24

1) PASSIVE DIFFUSION

Also known as non-ionic diffusion. It is defined as the difference in the drug concentration on either side of the membrane. Absorption of 90% of drugs. The driving force for this process is the concentration or electrochemical gradient.
25

08/10/2010

KLECOP, Nipani

Passive diffusion is best expressed by Ficks first law of diffusion which states that the drug molecules diffuse from a region of higher concentration to one of lower concentration until equilibrium is attained & the rate of diffusion is directly proportional to the concentration gradient across the membrane. dQ dt
=

D A Km/w h

(CGIT C)

Certain characteristic of passive diffusion can be generalized. a) Down hill transport

08/10/2010 KLECOP, Nipani 26

b) Greater the surface area & lesser the thickness of the membrane, faster the diffusion. c) Equilibrium is attained when the concentration on either side of the membrane become equal. d) Greater the membrane/ water partition coefficient of drug, faster the absorption. Passive diffusion process is energy independent but depends more or less on the square root of the molecular size of the drugs. The mol. Wt. of the most drugs lie between 100 to 400 Daltons which can be effectively absorbed passively.
08/10/2010 KLECOP, Nipani 27

2) Pore transport
Also known as convective transport, bulk flow or filtration. Important in the absorption of low mol. Wt. (less than 100). Low molecular size (smaller than the diameter of the pore) & generally water-soluble drugs through narrow, aqueous filled channels or pores in the membrane structure. e.g. urea, water & sugars. The driving force for the passage of the drugs is the hydrostatic or the osmotic pressure difference across the membrane.

08/10/2010 KLECOP, Nipani 28

The rate of absorption via pore transport depends on the number & size of the pores, & given as follows: dc dt
=

N. R2. A . C () (h)

where, dc = dt N = R = C = =
08/10/2010

rate of the absorption.


number of pores radius of pores concentration gradient viscosity of fluid in the pores
KLECOP, Nipani 29

3) CARRIER MEDIATED TRANSPORT MECHANISM

Involves a carrier (a component of the membrane) which binds reversibly with the solute molecules to be transported to yield the carrier solute complex which transverses across the membrane to the other side where it dissociates to yield the solute molecule The carrier then returns to its original site to accept a fresh molecule of solute. There are two types of carrier mediated transport system: a) facilitated diffusion b) active transport
KLECOP, Nipani 30

08/10/2010

a) Facilitated diffusion

This mechanism involves the driving force is concentration gradient. In this system, no expenditure of energy is involved (down-hill transport), therefore the process is not inhibited by metabolic poisons that interfere with energy production.
31

08/10/2010

KLECOP, Nipani

Limited importance in the absorption of drugs. e.g. Such a transport system include entry of glucose into RBCs & intestinal absorption of vitamins B1 & B2. A classical example of passive facilitated diffusion is the gastro-intestinal absorption of vitamin B12. An intrinsic factor (IF), a glycoprotein produced by the gastric parietal cells, forms a complex with vitamin B12 which is then transported across the intestinal membrane by a carrier system.

08/10/2010

KLECOP, Nipani

32

b) Active transport

More important process than facilitated diffusion. The driving force is against the concentration gradient or uphill transport. Since the process is uphill, energy is required in the work done by the barrier. As the process requires expenditure of energy, it can be inhibited by metabolic poisons that interfere with energy production.
33

08/10/2010

KLECOP, Nipani

If drugs (especially used in cancer) have structural similarities to such agents, they are absorbed actively. A good example of competitive inhibition of drug absorption via active transport is the impaired absorption of levodopa when ingested with meals rich in proteins. The rate of absorption by active transport can be determined by applying the equation used for Michalies-menten kinetics: dc = [C].(dc/dt)max dt Km + [C]
(dc/dt)max = maximal rate of drug absorption at high drug concentration. [C] = concentration of drug available for absorption Km = affinity constant of drug for the barrier.
08/10/2010 KLECOP, Nipani 34

Where,

4) IONIC OR ELECTROCHEMICAL DIFFUSION

This charge influences the permeation of drugs. Molecular forms of solutes are unaffected by the membrane charge & permeate faster than ionic forms. The permeation of anions & cations is also influenced by pH. Thus, at a given pH, the rate of permeation may be as follows: Unionized molecule > anions > cations

08/10/2010

KLECOP, Nipani

35

The permeation of ionized drugs, particularly the cationic drugs, depend on the potential difference or electrical gradient as the driving force across the membrane. Once inside the membrane, the cations are attached to negatively charged intracellular membrane, thus giving rise to an electrical gradient. If the same drug is moving from a higher to lower concentration, i.e., moving down the electrical gradient , the phenomenon is known as electrochemical diffusion.
KLECOP, Nipani 36

08/10/2010

5) ION PAIR TRANSPORT

It is another mechanism is able to explain the absorption of such drugs which ionize at all pH condition.

08/10/2010

KLECOP, Nipani

37

Transport of charged molecules due to the formation of a neutral complex with another charged molecule carrying an opposite charge. Drugs have low o/w partition coefficient values, yet these penetrate the membrane by forming reversible neutral complexes with endogenous ions. e.g. mucin of GIT. Such neutral complexes have both the required lipophilicity as well as aqueous solubility for passive diffusion. This phenomenon is known as ion-pair transport.
KLECOP, Nipani 38

08/10/2010

6) ENDOCYTOSIS

It involves engulfing extracellular materials within a segment of the cell membrane to form a saccule or a vesicle (hence also called as corpuscular or vesicular transport) which is then pinched off intracellularly.
39

08/10/2010

KLECOP, Nipani

In endocytosis, there are three process: Phagocytosis

A)

B)
C)

Pinocytosis
Transcytosis

08/10/2010

KLECOP, Nipani

40

A) Phagocytosis

08/10/2010

KLECOP, Nipani

41

B) Pinocytosis

This process is important in the absorption of oil soluble vitamins & in the uptake of nutrients.

08/10/2010

KLECOP, Nipani

42

C) Transcytosis

It is a phenomenon in which endocytic vesicle is transferred from one extracellular compartment to another.

08/10/2010

KLECOP, Nipani

43

Diagram Representing Absorption, Distribution, Metabolism and Excretion


The ultimate goal is to have the drug reach the site of action in a concentration which produces a pharmacological effect. No matter how the drug is given (other than IV) it must pass through a number of biological membranes before it reaches the site of action.
08/10/2010 KLECOP, Nipani 44

Rate dependent on polarity and size. Polarity estimated using the partition coefficient.

The greater the lipid solubility the faster the rate of diffusion
Smaller molecules (nm/A0) penetrate more rapidly. Highly permeable to O2, CO2, NO and H2O .

Large polar molecules sugar, aa, phosphorylated intermediates


poor permeability These are essential for cell function must be actively transported

08/10/2010

KLECOP, Nipani

45

MOVEMENT OF SUBSTANCES ACROSS CELL MEMBRANES

08/10/2010

KLECOP, Nipani

46

BIOLOGICAL FACTORS:

Penetration Of Drugs Through Gastro-intestinal Tract Penetration Of Drugs Through Blood Brain Barrier Penetration Of Drugs Through Placental Barrier Penetration Of Drugs Through Across The Skin Penetration Of Drugs Through The Mucous Membrane Of The Nose, Throat, Trachea, Buccal Cavity, Lungs ,Vaginal And Rectal Surfaces

PHYSIOLOGICAL FACTORS:

Gastrointestinal (Gi) Physiology Influence Of Drug Pka And Gi Ph On Drug Absorbtion Git Blood Flow Gastric Emptying Disease States
KLECOP, Nipani 47

08/10/2010

PENETRATION OF DRUGS THROUGH GASTRO-INTESTINAL TRACT


The Git barrier that separates the lumen of the stomach and intestine from systemic circulation and is composed of lipids, proteins and polysaccharides. Git mucosa is a semi permeable membrane across which various nutrients like Carbohydrates, Amino acids, Vitamins and foreign substances are transported and absorbed into the blood by various mechanisms like: 1. Passive diffusion 2. Pore transport 3. Facilitated transport 4. Active transport 5. Pinocytosis
08/10/2010 KLECOP, Nipani 48

1. PASSIVE DIFFUSION

Major process for absorption of more than 90% of drugs Diffusion follows Ficks law: The drug molecules diffuse from a region of higher concentration to a region of lower concentration till equilibrium is attained. Rate of diffusion is directly proportional to the concentration gradient across the membrane. Factors affecting Passive diffusion: Diffusion coefficient of the drug Related to lipid solubility and molecular wt. Thickness and surface area of the membrane Size of the molecule
KLECOP, Nipani 49

08/10/2010

08/10/2010

KLECOP, Nipani

50

2. PORE TRANSPORT

It involves the passage of ions through Aq. Pores (4-40 A0) Low molecular weight molecules (less than 100 Daltons) eg- urea, water, sugar are absorbed. Also imp. In renal excretion, removal of drug from CSF and entry of drugs into liver.

08/10/2010

KLECOP, Nipani

51

3. FACILITATED DIFFUSION

Carrier mediated transport (downhill transport) Faster than passive diffusion No energy expenditure is involved Not inhibited by metabolic poisons Important in transport of Polar molecules and charged ions that dissolve in water but they can not diffuse freely across cell membranes due to the hydrophobic nature of the phospholipids.

Eg. 1. entry of glucose into RBCs 2. intestinal absorption vitamin B1 ,B2 3. transport of amino acids thru permeases
08/10/2010 KLECOP, Nipani 52

08/10/2010

KLECOP, Nipani

53

4. ACTIVE TRANSPORT

Carrier mediated transport (uphill transport) Energy is required in the work done by the carrier Inhibited by metabolic poisons Endogenous substances that are transported actively include sodium, potassium, calcium, iron, glucose, amino acids and vitamins like niacin, pyridoxin. Drugs having structural similarity to such agents are absorbed actively Eg. 1. Pyrimidine transport system absorption of 5 FU and 5 BU 2. L-amino acid transport system absorption of methyldopa and levodopa
KLECOP, Nipani 54

08/10/2010

08/10/2010

KLECOP, Nipani

55

5. PINOCYTOSIS
Pinocytosis ("cell-drinking")

Uptake of fluid solute. A form of endocytosis in which small particles are brought into the cell in the form of small vesicles which subsequently fuse with lysosomes to hydrolyze, or to break down, the particles. This process requires energy in the form of (ATP). Polio vaccine and large protein molecules are absorbed by pinocytosis
KLECOP, Nipani 56

08/10/2010

08/10/2010

KLECOP, Nipani

57

PENETRATION OF DRUGS THROUGH BLOOD BRAIN BARRIER


A stealth of endothelial cells lining the capillaries. It has tight junctions and lack large intra cellular pores. Further, neural tissue covers the capillaries. Together , they constitute the so called BARRIER BLOOD BRAIN

Astrocytes : Special cells / elements of supporting tissue found at the base of endothelial membrane. The blood-brain barrier (BBB) is a separation of circulating blood and cerebrospinal fluid (CSF) maintained by the choroid plexus in the central nervous system (CNS).
KLECOP, Nipani 58

08/10/2010

08/10/2010

KLECOP, Nipani

59

Since BBB is a lipoidal barrier,


It allows only the drugs having high o/w partition coefficient to diffuse passively where as moderately lipid soluble and partially ionised molecules penetrate at a slow rate.

Endothelial cells restrict the diffusion of microscopic objects (e.g. bacteria ) and large or hydrophillic molecules into the CSF, while allowing the diffusion of small hydrophobic molecules (O2, hormones, CO2). Cells of the barrier actively transport metabolic products such as glucose across the barrier with specific proteins.

Various approaches to promote crossing the BBB by drugs:


Use of Permeation enhancers such as dimethyl sulfoxide (DMSO) Osmotic disruption of the BBB by infusing internal carotid artery with mannitol Use of Dihydropyridine redox system as drug carriers to the brain ( the lipid soluble dihydropyridine is linked as a carrier to the polar drug to form a prodrug that rapidly crosses the BBB )
KLECOP, Nipani 60

08/10/2010

PENETRATION OF DRUGS THROUGH PLACENTAL BARRIER

Placenta is the membrane separating fetal blood from the maternal blood. It is made up of fetal trophoblast basement membrane and the endothelium. Mean thickness (25 ) in early pregnancy and reduces to (2 ) at full term Many drugs having mol. wt. < 1000 daltons and moderate to high lipid solubility e.g. ethanol, sulfonamides , barbiturates, steroids , anticonvulsants and some antibiotics cross the barrier by simple diffusion quite rapidly . Nutrients essential for fetal growth are transported by carrier mediated processes
KLECOP, Nipani 61

08/10/2010

08/10/2010

KLECOP, Nipani

62

PENETRATION OF DRUGS THROUGH ACROSS THE SKIN


Skin is composed of three primary layers: the epidermis , which provides waterproofing and serves as a barrier to infection; the dermis , which serves as a location for the appendages of skin; and the hypodermis (subcutaneous adipose layer). The stratum corneum is the outermost layer of the epidermis and is composed mainly of dead keratinised cells (from lack of oxygen and nutrients). It has a thickness between 10 - 40 m. The dermis is the layer of skin beneath the epidermis. It contains the hair follicles, sweat glands, sebaceous glands, apocrine glands, lymphatic vessels and blood vessels. Hypodermis - Its purpose is to attach the skin to underlying bone and muscle as well as supplying it with blood vessels and nerves. The main cell types are fibroblasts, macrophages and adipocytes (the hypodermis contains 50% of body fat).

08/10/2010

KLECOP, Nipani

63

08/10/2010

KLECOP, Nipani

64

ROUTES OF PENETRATION

Through follicular region Through sweat ducts Through unbroken stratum corneum

FACTORS IN SKIN PERMEATION


1.

2.

3.
4.

Thickness of the skin layer: (Thickest on palms and soles & thinest on the face) Skin condition: permeability of skin is affected by age, disease state or injury. Skin temp.: permeability increases with increase in temp. Hydration state

APPROACHES TO ENHANCE SKIN PERMEATION


1.
2. 3. 4.

Innuction Iontophoresis Sonophoresis Magnetophoresis


KLECOP, Nipani 65

08/10/2010

Penetration Of Drugs Through The Mucous Membrane Of The Nose, Throat, Trachea, Buccal Cavity, Lungs ,Vaginal And Rectal Surfaces

The barrier for the drug absorption is the capillary endothelial membrane which is lipoidal and consists of pores . Thus, lipid soluble drugs can easily penetrate by diffusion and smaller drug molecules can penetrate by pore transport.

08/10/2010

KLECOP, Nipani

66

Gastrointestinal (GI) Physiology


pH
BUCCAL approx 6

Membrane
thin

Blood Supply
Good, fast absorption with low dose -

Surface Area
small

Transit Time
Short unless controlled

By-pass liver
yes

ESOPHAGUS

Very thick, no absorption Normal Lipophilic,acidic and neutral drugs

small

short

STOMACH

13

good

small

30 - 40 minutes, reduced absorption

no

DUODENUM

57

Normal Mainly lipohilic and neutral drugs

good

large

very short (6" long)

no

SMALL INTESTINE LARGE INTESTINE

6 -7

Normal All types of drugs -

good

very large 10 - 14 ft, 80 cm 2 /cm

about 3 hours

no

6.8 - 7

good

not very large 4 - long, up to 24 hr 5 ft

lower colon, rectum yes

08/10/2010

KLECOP, Nipani

67

SMALL INTESTINE :

Major site for absorption of most drugs due to its large surface area (0.33 m2 ). It is 7 meters in length and is approximately 2.5-3 cm in diameter. The Folds in small intestine called as folds of kerckring, result in 3 fold increase in surface area ( 1 m2). These folds possess finger like projections called Villi which increase the surface area 30 times ( 10 m2). From the surface of villi protrude several microvilli which increase the surface area 600 times ( 200 m2). Blood flow is 6-10 times that of stomach. PH Range is 57.5 , favourable for most drugs to remain unionised. Peristaltic movement is slow, while transit time is long. Permeability is high.

All these factors make intestine the best site for absorbtion of most drugs.
08/10/2010 KLECOP, Nipani 68

INFLUENCE OF DRUG pKa AND GI PH ON DRUG ABSORBTION


Drugs Very weak acids (pKa > 8.0) Site of absorption Unionized at all ph values Absorbed along entire length of GIT

Moderately weak acids (pKa 2.5 7.5)

Unionized in gastric ph Ionized in intestinal ph Better absorbed from stomach


Ionized at all ph values Poorly absorbed from git Unionized at all ph values Absorbed along entire length of GIT Ionized in gastric ph Unionized in intestinal ph Better absorbed from intestine Ionized at all ph values Poorly Absorbed from GIT

Strong acids (pKa <2.5) Very weak bases (pKa < 5) Moderately weak bases (pKa 5 11 )

Strong bases (pKa >11)


08/10/2010

KLECOP, Nipani

69

GIT BLOOD FLOW

It plays an imp. role in drug absorption by continuously maintaining the conc. Gradient across the epithelial membrane
Polar molecules that are slowly absorbed show no dependence on blood flow The absorption of lipid soluble drugs and molecules that are small enough to easily penetrate through Aq. pores is rapid and highly dependent on rate of blood flow

08/10/2010

KLECOP, Nipani

70

GASTRIC EMPTYING

The process by which food leaves the stomach and enters the duodenum. It is a RDS in drug absorbtion. Rapid Gastric Emptying Advisable when : Rapid onset of action is desired eg. Sedatives Dissolution occurs in the intestine eg. Enteric coated tablets Drugs not stable in gi fluids eg. penicillin G Drug is best absorbed from small intestine eg. Vitamin B12

Delay in Gastric Emptying recommended when Food promotes drug dissolution and absorbtion eg. Gresiofulvin Disintegration and dissolution is is promoted by gastric fluids
KLECOP, Nipani 71

08/10/2010

Factors affecting Gastric Emptying


Volume of Ingested As volume increases initially an increase then a Material decrease. Bulky material tends to empty more slowly than liquids
Type of Meal Gastric emptying rate: carbohydrates > proteins > fats

Temperature of Food Increase in temperature, increase in emptying rate Body Position Git PH Emotional state Disease states Lying on the left side decreases emptying rate and right side promotes it Retarded at low stomach PH and promoted at higher alkaline PH Anxiety promotes where as depression retards it gastric ulcer, hypothyroidism retards it, while duodenal ulcer, hyperthyroidism promotes it.
KLECOP, Nipani 72

08/10/2010

DISEASE STATES

CHF decreases blood flow to the Git, alters GI PH, secretions and microbial flora. Cirrhosis influences bioavailability mainly of drugs that undergo considerable 1st pass metabolism eg. Propranolol Git infections like cholera and food poisoning also result in malabsorbtion.

08/10/2010

KLECOP, Nipani

73

PHYSIO-CHEMICAL FACTORS
PHYSICAL FACTORS PHYSIO-CHEMICAL FACTORS

08/10/2010

KLECOP, Nipani

74

PHYSICAL FACTORS
1. PARTICLE SIZE

Smaller particle size, greater surface area then higher will be dissolution rate, because dissolution is thought to take place at the surface area of the solute( Drug). This study is imp. for drugs that have low aqueous solubility. Absorption of such drugs can be increased by increasing particle size by Micronization. ex. Griseofulvin, active intravenously but not effective when given orally.
08/10/2010 KLECOP, Nipani 75

1. PARTICLE SIZE

To poor soluble drug, disintegration agents and surface active agents may be added . ex. Bioavailability of Phenacetin is increased by tween 80. Micronization also reduces the dose of some drugs ex. the dose of griseofulvin is reduced to one half while the dose of spironolactone is reduced to one twentieth.

08/10/2010

KLECOP, Nipani

76

Lesser particle size is always not helpful


Ex. Micronization of Aspirin, phenobarbital, surface area and hence lesser dissolution rate Reasons: On their surface, hydrophobic drugs absorb air and reduce their wettability Particle having size below 0.1 micron reaggregate to form large particle Particle having certain micro size get electrical charge which preventing contact with wetting medium
08/10/2010 KLECOP, Nipani 77

lesser effective

Finally drug size reduction and subsequent increase in surface area and dissolution rate is always not useful. Ex. of such drugs are Penicillin G & Erythromycin These Drugs are unstable and degrade quickly in solution.

Sometime, reduction in particle size of nitrofurantoin and piroxicam increase gastric irritation
These problem can be overcome by Microencapsulation.

08/10/2010

KLECOP, Nipani

78

2. Crystal Form
Substance can exist either in a crystalline or amorphous form. When substance exist in more than one crystalline form, the different form are called polymorphs and the phenomena as polymorphism . Two types of Polymorphism 1) Enantiotropic polymorph ex. Sulfur 2) Monotropic polymorph ex. Glyceryl Stearates Polymorphs have the same chemical structure but different physical properties such as solubility, density, hardness etc. ex. Chlormphenicol has a several crystal form, and when given orally as a suspension, the drug concentration in the body was found to be dependent on the percentage of - polymorph in the suspension. The form is more soluble and better absorbed.
08/10/2010 KLECOP, Nipani 79

One of the several form of polymorphic forms is more stable than other. Such a stable form having low energy state and high melting point and least aqueous solubility The remaining polymorphs are called as metastable forms which have high energy state, low melting point and high aqueous solubilities. About 40% of all organic compounds exhibit polymorphism. Some drug exists in amorphous form which have no internal crystal structure. Such drugs have high energy states than crystal form hence they have greater aqueous solubility than crystalline form. Ex. Novobiocin, cortisone acetate.
08/10/2010 KLECOP, Nipani 80

3. Solvates And Hydrates Many drugs associate with solvent and forms solvates Solvent is water then it is called as hydrate eg. Anhydrous form of caffeine and theophylline dissolve more rapidly than hydrous form of these drugs. Solvate form of drugs with org. solvent may dissolve fast in water than non solvated form. eg. Fluorocortisone 4. Complexation This property can influence the effective drug concentration in gi fluids. Complexation of drug and gi fluids may alter the rate and extent of absorption

eg. Intestinal Mucin form complex with Streptomycin and Dihydro Streptomycin. In some cases, Poor water soluble drugs can be administered as water soluble complexes. eg. Hydroquinone with Digoxin.
08/10/2010 KLECOP, Nipani 81

5.Adsorption
It is a physical and surface phenomena where the drug molecules are held on the surface of some inert substances by vanderwalls forces. ex. Charcoal used as an antidote; When it is co-administered with promazine, then it reduces the rate and extent of absorption Cholestyramine reduces the absorption of warfarin.

6.Drug Stability And Hydrolysis In GIT


Drugs undergoes various reactions due to wide spectrum of ph and enzymatic activity of GI fluid namely acid and enzymatic hydrolysis.
eg. T of Penicillin G= 1 min. at pH 1 T of Penicillin G= 9 min. at pH2
So it means Penicillin G is stable at less acidic pH Erythromycin and its esters are unstable at gastric fluid (T=Less than 2 min.)
08/10/2010 KLECOP, Nipani 82

7. Salts Na or K salts of weak acid dissolves rapidly than free acid. ex. Na salts of Novobiocin shows improved bioavailability Certain salts also may have low solubility and dissolution rate.

ex. Al salts of weak acid and pamoate salt of weak base

8. Presence Of Surfactant
Use of wetting agent and Solubilizing agent improve the Dissolution rate & absorption of drugs. Ex. Tween 80 increase the rate & extent of absorption of Phenacetin. 9. Dissolution Disintegration is the formation of dispersed granules from an intact solid dosage form whereas the dissolution is the formation of solvated drug molecules from the drug
08/10/2010 KLECOP, Nipani 83

SOLID DRUG
DISSOLUTION

DRUG AT ABSORPTION SITE


ABSORPTION

DRUG IN SYSTEMIC CIRCULATION


08/10/2010 KLECOP, Nipani 84

NOYES AND WHITNEYS EQUATION

dc/dt = KS(CS-C) Where, dc/dt = Rate constant, K = constant, S = surface area of the dissolving solid, Cs=solubility of the drug in the solvent, C=concentration of drug in the solvent at time t. Constant K=D/h Where, D is the diffusion coefficient of the dissolving material and h is the thickness of the diffusion layer Here, C will always negligible compared to Cs So, dc/dt=DSCs/h
KLECOP, Nipani

08/10/2010

85

P H Y S I C O C H E M I C A L FA C TO R S 1) pH PARTITION THEORY (Brodie) :


It explain drug absorption from GIT and its distribution across biomembranes. Drug(>100 daltons) transported by passive diffusion depend upon: dissociation constant, pKa of the drug lipid solubility, K o/w pH at absorption site. Most drugs are either weak acids or weak bases whose degree of ionization is depend upon pH of biological fluid.
08/10/2010 KLECOP, Nipani 86

For a drug to be absorbed, it should be unionized and the unionized portion should be lipid soluble.

The fraction of drug remaining unionized is a function of both Dissociation constant (pKa) and pH of solution.

The pH partition theory is based on following assumption:


GIT acts as a lipoidal barrier to the transport of the drug The rate of absorption of drug is directly proportional to its fraction of unionised drug Higher the lipophilicity of the unionised degree, better the absorption.
08/10/2010 KLECOP, Nipani 87

HENDERSON HASSELBATCH EQUATION


For acid, pKa - pH = log[ Cu/Ci ] For base, pKa pH = log[ Ci/Cu ] Eg. Weak acid aspirin (pKa=3.5) in stomach (pH=1) will have > 99%of unionized form so gets absorbed in stomach Weak base quinine (pKa=8.5) will have very negligible unionization in gastric pH so negligible absorption Several prodrugs have been developed which are lipid soluble to overcome poor oral absorption of their parent compounds.
08/10/2010 KLECOP, Nipani 88

eg. Pivampicilin, the pivaloyloxy-methyl ester of ampicilin is More lipid soluble than ampicilin. Lipid solubility is provided to a drug by its partition coefficient between An organic solvent and water or an aq. Buffer (same pH of ab. Site) E.g. Barbital has a p.c. of 0.7 its absorption is 12% Phenobarbital ( p.c = 4.8 absorption=12%) Secobarbital (p.c =50.7 absorption=40%)

08/10/2010

KLECOP, Nipani

89

2)DRUG SOLUBILITY
The absorption of drug requires that molecule be in solution at absorption site. Dissolution, an important step, depends upon solubility of drug substance. pH solubility profile: pH environment of GIT varies from Acidic in stomach to slightly Alkaline in a small intestine.

1)Basic drug 2)Acidic drug


08/10/2010

soluble 1) Acidic medium( stomach) 2) basic medium( intestestine)


KLECOP, Nipani 90

Improvement of solubility:

Addition of acidic or basic excipient Ex: Solubility of Aspirin (weak acid) increased by addition of basic excipient. For formulation of CRD , buffering agents may be added to slow or modify the release rate of a fast dissolving drug.

08/10/2010

KLECOP, Nipani

91

PHARMACEUTICAL FACTORS
MEANS Absorption rate depends on the dosage Form which is administred,ingredients used, procedures Used in formulation of dosage forms.

The availability of the drug for absorption from the dosage forms is in order.
Solutions > Suspensions > capsules > Compressed Tablets > Coated tablets.

08/10/2010

KLECOP, Nipani

92

SOLUTIONS
Shows maximum bioavailability and factors affecting Absorption from solution are as follows
1. Chemical stability of drug 2. Complexation: between drug and exipients of formulation to increase the solubility, stability. 3. Solubilization: incorporation of drug into micelles to increase the solubility of drugs. 4. Viscosity 5. Type of solution: Whether aqueous or oily solution.
08/10/2010 KLECOP, Nipani 93

SUSPENSIONS: It comes next after solutions with respect to bioavailability Factors that affects absorption from suspensions are 1. Particle size and effective surface area of dispersed phase
2. Crystal form of drug: some drug can change their crystal structure. Eg. Sulfathiazole can change its polymorphic form, it can be overcome by addition by adding PVP. 3. Complexation: Formation of nonabsorbable complex between drug and other ingredients. Eg. Promazine forms a complex with attapulgite.
08/10/2010 KLECOP, Nipani 94

4. Inclusion of surfactant Eg. The absorption of phenacitin from suspension is increased in presence of tween 80. 5. Viscosity of suspension Eg. Methyl cellulose reduces the rate and absorption of nitrofurantoin 6. Inclusion of colourants: Eg. Brilliant blue in phenobarbitone suspension.

08/10/2010

KLECOP, Nipani

95

CAPSULES Two types of capsule 1. Hard gelatin capsule 2. Soft gelatin capsule

08/10/2010

KLECOP, Nipani

96

HARD GELATIN CAPSULE The rate of absorption of drugs from capsule is function Of some factors. 1.Dissolution rate of gelatin shell. 2.The rate of penetration of GI fluids into encapsulated mass 3.The rate at which the mass disaggregates in the GI fluid 4. The rate of dissolution. 5. Effect of excipients; a).Diluents b).Lubricants c). Wetting characteristics of drug d).Packing density

08/10/2010

KLECOP, Nipani

97

SOFT GELATIN CAPSULE SGS has a gelatin shell thicker than HGS,but shell is Plasticized by adding glycerin,sorbitol.SGS may used To contain non aqueous solution or liquid or semi solid. SGC have a better bioavailability than powder filled HGC And are equivalent to emulsions. Eg. Quinine derivative was better absorbed from SGC Containing drug base compared with HGC containing HCl salts. Grieseoflavin exhibited 88% absorption from soft gelatin Capsules compared to HGC(30%)
08/10/2010 KLECOP, Nipani 98

TABLETS 1.Compressed tablets 2. Coated tablets

08/10/2010

KLECOP, Nipani

99

Compressed tablets Bioavailability are more due to large reduction in surface area.
A Intact tablets a K1 granules B

primary drug particle K3

K2

Drug in GI fluid

K4
Drug absorbed in body
08/10/2010 KLECOP, Nipani 100

The rate constants decrease in the following order.


K3>>K2>>K1

The overall dissolution rate and bioavailability of a poor Soluble drugs is influenced by 1.The physicochemical properties of liberated particles. 2. The nature and quantity of additives. 3. The compaction pressure and speed of compression. 4. The storage and age of tablet

08/10/2010

KLECOP, Nipani

101

1.Effect of diluents : Na Salicylates + starch = Faster dissolution Na salicylates + lactose=Poor dissolution. 2.Effect of Granulating agent: Phenobarbital + Gelatin solution=Faster dissolution Phenobarbital+PEG 6000= poor dissolution. 3.Effect of lubricants: Magnesium stearate will retard the dissolution of aspirin tablet Whereas SLS enhance the dissolution.

08/10/2010

KLECOP, Nipani

102

4.Effect of disintegrants: Starch tend to swell with wetting and break apart the dosage form. It is reported that 325mg of salicylic acid tablet were prepared by using different concentrations (5%,10%,20%) and max. dissolution was achieved With 20% starch.

5. Effect of colorants:

6.Effect of Compression force:

08/10/2010

KLECOP, Nipani

103

COATED TABLETS: There are three types of coating Sugar coating Film coating Enteric coating
SUGAR COATING: Sugar,Shellac,fatty glycerides, bees wax, silicone resin Sub coating agent: Talc,acacia,starch. FILM COATING: Polymers, dispersible cellulose derivatives like HPMC CMC. ENTERIC COATING: Shellac, cellulose acetate phthalate etc.
08/10/2010 KLECOP, Nipani 104

Factors affecting the drug release are 1.Thickness of coating e.g.. Quinine shows decrease in rate of absorption if coated with cellulose acetate phthalate. 2.The amount of dusting powder: 3.Effect of ageing: e.g. The shellac coated tablets of Para amino salicylic acid when given after two years plasma concentration of 6-7mg/100ml. However the tablets stored for 3 years showed plasma concentration of only 2mg/100ml which is the sub therapeutic effect.
08/10/2010 KLECOP, Nipani 105

SUBLINGUAL / BUCCAL ROUTE

SUBLINGUAL ROUTE: the dosage form is placed beneath the tongue. BUCCAL ROUTE: Dosage form is placed between the cheek and teeth or In the cheek pouch. Drugs administered by this route are supposed to produce systemic drug effects, and consequently, they must have good absorption from oral mucosa. Oral mucosal regions are highly vascularised therefore rapid onset of action is observed. For Eg, anti-anginal drug Nitroglycerin.
KLECOP, Nipani 106

08/10/2010

SUBLINGUAL / BUCCAL ROUTE


Blood perfuses oral regions drains directly into the general circulation. Barrier to drug absorption from these routes is epithelium of oral mucosa. Passive diffusion is the major mechanism of absorption of most drugs. In general, sublingual tablets are designed to dissolve slowly to minimize possibility of swallowing the dose. Exception include: Nitroglycerin, Isosorbide dinitrate tablets which dissolves within minutes in buccal cavity to provide prompt treatment of acute anginal episodes.

08/10/2010 KLECOP, Nipani 107

08/10/2010

KLECOP, Nipani

108

08/10/2010

KLECOP, Nipani

109

Factors to be considered:
Lipophilicity of drug: The lipid solubility should be high for absorption. 1. Salivary secretion: drug should be soluble in buccal fluid. 2. pH of saliva: pH of saliva is usually 6. 3. Storage compartment: some drugs have storage compartment in buccal mucosa. Eg, Buprenorphine 4. Thickness of oral epithelium: Sublingual absorption is faster than buccal, because former region is thinner than that of buccal mucosa.

08/10/2010

KLECOP, Nipani

110

FACTORS LIMITTING DRUG ADMINISTRATION:


1. 2.

Limited mucosal surface area. Taste of medicament and discomfort. EXAMPLES: Nitroglycerin, Isosorbide dinitrate, Progesterone, Oxytocin, Fenosterol, Morphine.

08/10/2010

KLECOP, Nipani

111

RECTAL ADMINISTRATION:

Absorption across the rectal mucosa occurs by passive diffusion. This route of administration is useful in children, old people and unconscious patients. Eg., drugs that administered are: aspirin, acetaminophen, theophylline, indomethacin, promethazine & certain barbiturates.

08/10/2010

KLECOP, Nipani

112

PARENTERAL ROUTES:
.

08/10/2010

KLECOP, Nipani

113

INTRAVENOUS ROUTE:
Absorption phase is bypassed (100% bioavailability) 1.Precise, accurate and almost immediate onset of action, 2. Large quantities can be given, fairly pain free 3. Greater risk of adverse effects a. High concentration attained rapidly b. Risk of embolism
08/10/2010 KLECOP, Nipani 114

INTRAVENOUS ROUTE:

This route is used when a rapid clinical response is required like treatment of epileptic seizures, acute asthmatic and cardiac arrhythmias. There may also be a danger of precipitation of drug in the vein if the inj. is too rapidly. This could result in thrombophlebitis. This mode of administration is required with drugs having short half lives and narrow therapeutic index. Bioavailability is not considered by this route. Mainly antibiotics are administered by this route.
KLECOP, Nipani 115

08/10/2010

Intra arterial injection

In this route the drugs are injected directly into the artery. It is mainly used for cancer chemotherapy. It increased drug delivery to the area supplied by the infused artery and decreased drug delivery to systemic circulation.

08/10/2010

KLECOP, Nipani

116

INTRA MUSCULAR INJECTION

Absorption of drug from muscles is rapid and absorption rate is perfusion rate limited. Polypeptides of less than approx 5000 gram per mole primarily pass through capillary pathway Greater than about 20000 g/mol are less able to traverse capillary wall, they primarily enter blood via lymphatic pathway.

08/10/2010

KLECOP, Nipani

117

Factors determining rate of drug absorption:


1. Vascularity to the inj. Site: Blood flow rates to intramuscular tissues are: Arm (deltoid) > thigh (vastus lateralis) > buttocks (gluteus maximus). 2. Lipid solubility and ionisation of drug. 3. Molecular size of drug. 4. Volume of inj. And drug concentration. 5. pH & viscosity of inj. vehicle.

08/10/2010

KLECOP, Nipani

118

SUBCUTANOUS ROUTE:
1. Slow and constant absorption 2. Absorption is limited by blood flow, affected if circulatory problems exist. 3. The blood supply to this is poorer than that of muscular tissue. 4. Concurrent administration of vasoconstrictor will slow absorption, e.g. Epinephrine. 5. The absorption is hastened by massage, application of heat to increase blood flow and inclusion of enzyme Hyaluronidase in drug solution. eg. Insulin.
08/10/2010 KLECOP, Nipani 119

08/10/2010

KLECOP, Nipani

120

TOPICAL ADMINISTRATION:
MUCOSAL MEMBRANES(eye drops, antiseptic, sunscreen, nasal, etc.) SKIN a. Dermal - rubbing in of oil or ointment (local action) b. Transdermal - absorption of drug through skin (systemic action) i. stable blood levels ii. no first pass metabolism iii. drug must be potent.
08/10/2010 KLECOP, Nipani 121

Skin consist of three layers : Epidermis Dermis Subcutaneous fat tissue The main route for the penetration of the drugs is generally through epidermal layer Stratum corneum is the rate limiting barrier in passive percutaneous absorption of drug.

08/10/2010

KLECOP, Nipani

122

The stratum corneum is the outermost layer of the epidermis and is composed mainly of dead keratinized cells (from lack of oxygen and nutrients). It has a thickness between 10 - 40 m. The dermis is the layer of skin beneath the epidermis. It contains the hair follicles, sweat glands, sebaceous glands, apocrine glands, lymphatic vessels and blood vessels. Hypodermis - Its purpose is to attach the skin to underlying bone and muscle as well as supplying it with blood vessels and nerves. The main cell types are fibroblasts, macrophages and adiposities (the hypodermis contains 50% of body fat).

08/10/2010

KLECOP, Nipani

123

08/10/2010

KLECOP, Nipani

124

OCULAR ADMINISTRATION

Eye is the most easily accessible site for topical administration of a medication. Topical application of drug to eyes meant for : Mydriasis, miosis, anaesthesia, treatment of infection, glaucoma etc. Opthalmic solution are administered into cul-de-sac. Barrier to intra occular penetration is cornea. It possess both hydrophilic and lipophilic characterstics. pH of lacrimal fluid is 7.4. pH of lacrimal fluid influences absorption of weak electrolyte like Pilocarpine.
KLECOP, Nipani 125

08/10/2010

OCULAR ADMINISTRATION

High pH of formulation: decrease tear flow and Low pH of formulation: increases tear flow. Human eye can hold around 10 microlitre of fluid. So small volume in concentrated form increases effectiveness. Viscosity empartners increases bioavailability eg, oily solutions, ointment etc. Systemic entry of drug occur by lacrimal duct which drains lacrimal fluid into nasal cavity.
KLECOP, Nipani 126

08/10/2010

Composition of eye

Water - 98% Solid -1.8% Organic element Protein - 0.67%, sugar - 0.65%, Nacl - 0.66% Other mineral element sodium, potassium and ammonia - 0.79%

08/10/2010

KLECOP, Nipani

127

08/10/2010

KLECOP, Nipani

128

Characteristics required to optimize ocular drug delivery system

Good corneal penetration. Prolong contact time with corneal tissue. Simplicity of instillation for the patient. Non irritative and comfortable form (viscous solution should not provoke lachrymal secretion and reflex blinking) Appropriate rheological properties concentrations of the viscous system.
KLECOP, Nipani 129

08/10/2010

Advantages

Increase ocular residence.. Improving bioavailability Prolonged drug release.. better efficacy Less visual & systemic side effects Increased shelf life Exclusion of preservatives Reduction of systemic side effects Reduction of the number of administration Better patient compliance Accurate dose in the eye. a better therapy
KLECOP, Nipani 130

08/10/2010

FACTOR INFLUENCING PERCUTANEOUS ABSORPTION


1. 2. 3. 4. 5. 6.

7.
8.

Drug release from dosage form Drug concentration in the formulation Drug oil water partition coefficient. Drug affinity to the skin tissue Surface area Site of application Hydration of skin Nature of vehicle used
KLECOP, Nipani 131

08/10/2010

FACTOR INFLUENCING PERCUTANEOUS ABSORPTION


9. Rubbing
10. Contact period 11. Permeation enhancers

08/10/2010

KLECOP, Nipani

132

INHALATIONAL ROUTE:
1.Gaseous and volatile agents and aerosols. 2.Rapid onset of action due to rapid access to circulation a.Large surface area b.Thin membranes separates alveoli from circulation c.High blood flow Particles larger than 20 micron and the particles impact in the mouth and throat. Smaller than 0.5 micron and they aren't retained.

08/10/2010

KLECOP, Nipani

133

INTRA NASAL ADMINISTRATION

Drugs generally administered by intra nasal route for treatment of local condition such as perennial rhinitis, allergic rhinitis and nasal decongestion etc. Absorption of lipophilic drugs through nasal mucosa by passive diffusion and absorption of polar drugs by pore transport. Rate of absorption of lipophilic drugs depend on their molecular weight. Drugs with molecular weight less than 400 daltons exhibit higher rate of absorption.

08/10/2010

KLECOP, Nipani

134

cont

Drugs with molecular weight 1000 daltons show moderate rate of absorption. Presently nasal route is becoming popular for systemic delivery of peptide and proteins, this is because of high permeability of nasal mucosa with vasculature.

08/10/2010

KLECOP, Nipani

135

08/10/2010

KLECOP, Nipani

136

Advantages

Rapid drug absorption via highly-vascularized mucosa Rapid onset of action Ease of administration, non-invasive Avoidance of the gastrointestinal tract and first-pass metabolism Improved bioavailability Lower dose/reduced side effects Improved convenience and compliance Self-administration.
KLECOP, Nipani 137

08/10/2010

Disadvantages

Nasal cavity provides smaller absorption surface area when compared to GIT. Relatively inconvenient to patients when compared to oral delivery since there is possibility of nasal irritation. The histological toxicity of absorption enhancers used in the nasal drug delivery system is not yet clearly established.
KLECOP, Nipani 138

08/10/2010

Enhancement in absorption

Following approaches used for absorption enhancement :Use of absorption enhancers Increase in residence time. Administration of drug in the form of microspheres. Use of physiological modifying agents

08/10/2010

KLECOP, Nipani

139

Enhancement in absorption

Use of absorption enhancers:-

Absorption enhancers work by increasing the rate at which the drug pass through the nasal mucosa. Various enhancers used are surfactants, bile salts, chelaters, fatty acid salts, phospholipids, cyclodextrins, glycols etc.

08/10/2010

KLECOP, Nipani

140

Various mechanisms involved in absorption enhancements are:

Increased drug solubility Decreased mucosal viscosity Decrease enzymatic degradation Increased Paracellular transport Increased transcellular transport
KLECOP, Nipani 141

08/10/2010

Various mechanisms involved in absorption enhancements are:

Increase in residence time:By increasing the residence time the increase in the higher local drug concentration in the mucous lining of the nasal mucosa is obtained. Various mucoadhesive polymers like methylcellulose, carboxy methyl cellulose or polyarcylic acid are used for increasing the residence time.
KLECOP, Nipani 142

08/10/2010

Various mechanisms involved in absorption enhancements are:

Use of physiological modifying agents:These agents are vasoactive agents and exert their action by increasing the nasal blood flow. The example of such agents are histamine, leukotrienene D4, prostaglandin E1 and -adrenergic agents like isoprenaline and terbutaline.
KLECOP, Nipani 143

08/10/2010

Applications of nasal drug delivery


A.

Nasal delivery of organic based pharmaceuticals :Various organic based pharmaceuticals have been investigated for nasal delivery which includes drug with extensive presystemic metabolism. E.g. Progesterone, Estradiol, Nitroglycerin, Propranolol, etc.

08/10/2010

KLECOP, Nipani

144

Applications of nasal drug delivery


B.

Nasal delivery of peptide based drugs :Nasal delivery of peptides and proteins is depend on The structure and size of the molecule. Nasal residence time Formulation variables (pH, viscosity)

E.g. calcitonin, secretin, albumins, insulin, glucagon, etc.


KLECOP, Nipani 145

08/10/2010

PULMONARY ADMINISTRATION The drugs may be administered for local action of bronchioles or their systemic effects through absorption of lungs. Inhalation sprays and aerosols are used to deliver the drugs to the lungs. Larger surface area of alveoli, high permeability of alveolar epithelium for drug penetration, and a rich vasculature are responsible for rapid absorption of drugs by this route
KLECOP, Nipani 146

08/10/2010

PULMONARY ADMINISTRATION

In general particles greater than 10mm are retained in the throat and upper airways whereas fine particles reach the pulmonary epithelium Drugs generally administered by this route are bronchodilators (e.g.. Salbutamol, isoproterenol), antiallergic (e.g.. Cromolym sodium), and antiinflammatory (e.g.. Betamethasone, dexamethasone).
08/10/2010 KLECOP, Nipani 147

08/10/2010

KLECOP, Nipani

148

Advantages

Smaller doses can be administered locally.

Reduce the potential incidence of adverse systemic effect. It used when a drug is poorly absorbed orally, e.g. Na cromoglicate. It is used when drug is rapidly metabolized orally, e.g. isoprenaline
KLECOP, Nipani 149

08/10/2010

IN-VITRO METHODS

Everted small intestine sac method. Everted sac modification. Circulation technique. Everted intestinal ring or slice technique.
KLECOP, Nipani 150

08/10/2010

Why in-vitro studies

Because of economical & ethical limitations of in-vivo studies. Simple & provide valuable information. To assess the major factors involved in absorption. Predict the rate & extent of drug absorption. Procedures are of great value during screening of new drug candidates. Carried out outside the body. Used to assess permeability of drug using animal tissues.
KLECOP, Nipani 151

08/10/2010

Everted small intestine sac technique


Isolation of rat intestine

Inverting the intestine

Filling the sac with drug free buffer solution

Immersion of sac in Erlenmeyer flask containing drug buffer solution


08/10/2010 KLECOP, Nipani

Contd

152

Flask & its contents oxygenated & agitated at 37oC for specific period of time

After incubation, the serosal content is assayed for drug content

08/10/2010

KLECOP, Nipani

153

Figure( reverted sac technique)


Serosal side

Mucosal side (intestinal segment before eversion) Serosal side


Buffer solution

Ligature Mucosal side


08/10/2010 KLECOP, Nipani (after eversion) 154

Advantages

Prolongs the viability & integrity of the preparation after removal from the animal. Convenience & accuracy with respect to drug analysis. The epithelial cells of the mucosal surface are exposed directly to the oxygenated mucosal fluid.

Difficulty in obtaining more than one sample per intestinal segment


08/10/2010 KLECOP, Nipani 155

Everted sac modification

Crane & Wilson modification. Essential features of simple sac methods are retained. Modification- the intestine is tied to a cannula.
KLECOP, Nipani 156

08/10/2010

cannula Plain buffer

Buffer solution with drug

Water maintained at aerator 37o C 08/10/2010 KLECOP, Nipani (FIG: EVERTED SAC MODIFICATION)

157

Procedure
Animal fasted for 20-24hrs

Water is allowed ad libitum

Animal killed with blow on head or anesthetized with ether or chloroform Entire small intestine is everted
08/10/2010 KLECOP, Nipani 158

Contd

Segments of 5-15cm length are cut from specific region of the intestine

Distal ends tied & proximal end is attached to cannula

Segments suspended in 40-100ml of drug mucosal solution.

About 1ml/5cm length of drug free buffer is then placed in serosal compartment

Mucosal solution aerated


08/10/2010 KLECOP, Nipani 159

How to determine the rate of drug transfer

The entire volume of serosal solution is removed from the sac at each time interval with the help of syringe & it is replaced with fresh buffer solution. The amount of drug that permeates the intestinal mucosa is plotted against time to describe the absorption profile of the drug at any specific pH.
KLECOP, Nipani 160

08/10/2010

Advantages

A number of different solutions may be tested with a single segment of the intestine unlike in the sac technique. Simple & reproducible. It distinguishes between active & passive absorption. It determines the region of the small intestine where absorption is optimal, particularly in the case of active transport. Also used to study the effect of pH, surface active agents, complexation & enzymatic reaction.
KLECOP, Nipani 161

08/10/2010

Disadvantages

The intestinal preparation is removed from the animal as well as from its blood supply. Under these conditions, the permeability characteristics of the membrane are significantly altered. The rate of transport of drug as determined from the everted sac technique, may be slower than in the intact animal.
KLECOP, Nipani 162

08/10/2010

Circulation technique

Small intestine may or may not be everted. In this method either entire small intestine of small lab animal or a segment is isolated. Oxygenated buffer containing the drug is circulated through the lumen. Drug free buffer is also circulated on the serosal side of the intestinal membrane & oxygenated. Absorption rate from the lumen to the outer solution are determined by sampling both the fluid circulating through the lumen.
KLECOP, Nipani 163

08/10/2010

Advantages

This is applicable to kinetic studies of the factors affecting drug absorption. Both surface are oxygenated. Eversion is not necessary.

08/10/2010

KLECOP, Nipani

164

Everted intestinal ring or slice technique


The entire small intestine(everted) is isolated from fasted expt animal

Intestine cut wit scalpel or scissors into ring like slices, 0.1-0.5cm length

Intestine washed with buffer & dried by blotting with filter paper

Dried rings transferred to stoppered flask containing buffer with drug at 37oC
08/10/2010 KLECOP, Nipani

Contd165

Contents are continuously agitated & aerated.

At selected time intervals, the tissues slices are assayed for drug content

08/10/2010

KLECOP, Nipani

166

Advantages

Simple & reproducible.

Kinetic studies can be performed.

Process of cutting the intestine into rings may expose


highly permeable areas of cut or damage tissue to medium.

MAJOR DISADVANTAGE OF IN-VITRO METHODS is that the are based on approximation & oversimplification of the actual in-vivo conditions.
08/10/2010 KLECOP, Nipani 167

In-situ methods

Absorption from small intestine.

Perfusion technique. Intestinal loop technique.

Absorption from the stomach.


KLECOP, Nipani 168

08/10/2010

Why in-situ studies.

In this method the animals blood supply remains intact & thus the results of rate of absorption determined may be more realistic than those from in-vitro techniques. Alternative means to in-vivo models in evaluating the relative contribution of GI absorption to oral bioavailability. Act as bridge between in-vitro & in-vivo methods. Mimic the in-vivo physiological process with significant reduction in cost & time.
KLECOP, Nipani 169

08/10/2010

ABSORPTION FROM SMALL INTESTINE


Adult male rats fasted for about 16-24hrs. Animal anesthetized, a midline abdominal incision is made.

isolation & cannulation of Small intestine


08/10/2010 KLECOP, Nipani

Contd

170

Replacement of intestine.

Incision closed & duodenal cannula is attached to an infusion pump Intestine cleared off particulate matter using drug free buffer (1.5ml/30min)

Drug buffer solution is perfused (1.5ml/30min)


08/10/2010 KLECOP, Nipani

Contd

171

Samples at 10min interval collected from ileal cannula

Samples assayed for drug content

Relative rate of absorption calculated Relative rate of absorption = difference in the drug concentration entering & leaving the intestine
08/10/2010 KLECOP, Nipani 172

Figure

08/10/2010

KLECOP, Nipani

173

Here, single or multiple intestinal loops are used for studying absorption Adult male rat fasted & water with held for 1-2hrs before expt. Under anesthesia an abdominal incision is made & small intestine exposed. Placement of proximal ligature & distal ligature.

Introduction of drug solution.


08/10/2010 KLECOP, Nipani 174

Contd..

Replacement of intestinal loop.

After a predetermined period of time, animal is sacrificed.

Intestinal loop is rapidly excised & homogenized.

The amount of drug unabsorbed is determined.


08/10/2010 KLECOP, Nipani 175

For preparing multiple loops, the procedure is identical to single loop preparation with a distance of approximately one half inch left between successive loops.

Advantages

Simple & reproducible.

Only 1 sample can be obtained from the experimental animal.


08/10/2010 KLECOP, Nipani 176

Absorption from the stomach


Fasted adult male rats anesthetized, stomach exposed & cardiac end ligated.

Introduction of cannula (pylorus).

Lumen washed several times with saline & subsequently with 0.1N HCl containing 0.15M NaCl

Drug solution of known concentration is introduced into the stomach


08/10/2010 KLECOP, Nipani

Contd.

177

After 1hr, the drug solution is removed from the gastric pouch & assayed for drug content.

% of drug absorbed in 1hr may be calculated.


The gastric pouch may also be homogenized & analyzed for drug.

In-situ techniques equate absorption with loss of drug from the GI lumen & if a drug is significantly accumulated or metabolized in gut wall, one will get an overestimate of the amount of drug absorbed
08/10/2010 KLECOP, Nipani 178

In-vivo methods

Direct method.

Indirect method.

08/10/2010

KLECOP, Nipani

179

Why in-vivo studies

Only method to assess the importance of many factors likeGastric emptying. Intestinal motility. Effect of drug on GIT.

The influence of dosage form variables on drug absorption can also be studied.
KLECOP, Nipani 180

08/10/2010

Direct method

The drug level in blood or urine is determined as a function of time. Absorption studies on experimental animals & clinical trials. Selection of experimental animals- pigs, dogs, rabbits, rat.
KLECOP, Nipani 181

08/10/2010

Procedure
A blank urine or blood sample is taken for the test animal before the experiment.

Administration of test dosage form.

Blood or urine sampling.

Assay for drug content & determination of rate & extent of drug absorption.
08/10/2010 KLECOP, Nipani 182

Indirect method

Adopted when the measurement of drug concentration in blood or urine is difficult or not possible. Pharmacological response is taken as the index of drug absorption. LD 50 appears to be dependent on the rate of absorption of drug & hence on the rate of dissolution. A plot of log dose vs. duration of response time is plotted.
KLECOP, Nipani 183

08/10/2010

Log dose

Fka/2.303

x
Duration of response time
Where,
F= bioavailability. Ka= the absorption rate constant. d= threshold dose
08/10/2010 KLECOP, Nipani 184

REFERENCES
1. Biopharmaceutics & pharmacokinetics by D.M.Brahmankar & Sunil B. Jaiswal. 2. Biopharmaceutics & pharmacokinetics by P.L.Madan. 3. Biopharmaceutics & pharmacokinetics by G.R.Chatwal. 4. Human anatomy & physiology by Tortora. 5. www.google.com.

08/10/2010

KLECOP, Nipani

185

Thank you
Cell No: 00919742431000 E-mail: bknanjwade@yahoo.co.in

08/10/2010

KLECOP, Nipani

186

Вам также может понравиться